No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US Stock MarketDetailed Quotes
GDRX GoodRx
- 6.960
- -0.010-0.14%
Close Apr 24 16:00 ET
- 6.960
- 0.0000.00%
Post 16:01 ET
2.61BMarket Cap-348000P/E (TTM)
7.130High6.840Low803.59KVolume7.000Open6.970Pre Close5.59MTurnover1.01%Turnover RatioLossP/E (Static)374.94MShares9.37052wk High3.43P/B551.85MFloat Cap4.13552wk Low--Dividend TTM79.29MShs Float64.219Historical High--Div YieldTTM4.16%Amplitude3.820Historical Low6.960Avg Price1Lot Size
Full Hours
- 5D
- 1D
- 1W
- 1M
- 1Q
- 1Y
Trade Overview
Unit: --
Capital Trend
IntradayDayWeekMonth
No Data
News
Investor Optimism Abounds GoodRx Holdings, Inc. (NASDAQ:GDRX) But Growth Is Lacking
GoodRx Holdings, Inc.'s (NASDAQ:GDRX) price-to-sales (or "P/S") ratio of 3.2x may not look like an appealing investment opportunity when you consider close to half the companies in the Healthcare Serv
Analysts Are Bullish on These Healthcare Stocks: GoodRx Holdings (GDRX), Arcutis Biotherapeutics (ARQT)
Press Release: GoodRx Announces Date for First Quarter 2024 Earnings Release and Conference Call
GoodRx Announces Date for First Quarter 2024 Earnings Release and Conference Call SANTA MONICA, Calif.--(BUSINESS WIRE)--April 11, 2024-- GoodRx Holdings, Inc. (Nasdaq: GDRX) ("GoodRx" or the "Compa
R1 RCM, Health Catalyst Downgraded as KeyBanc Reviews Health-tech Space
GoodRx Holdings Analyst Turns Bullish Ahead Of Q1 Earnings
GoodRx Holdings Inc (NASDAQ:GDRX) got an upgrade last month from Wells Fargo analyst. Despite being a "re-accelerating high-growth, high-margin company," the stock was trading at a discount both to it
GoodRx Stock Upgraded on Growth Potential
Comments
Filed to sell 99 million shares for a shareholder
$GoodRx(GDRX.US$ gonna sell slivers lakes stake and kill the business.. great short
GoodRx Holdings' ROCE trend is concerning. Despite reinvestment in its business, shrinking returns and a significant stock price drop hint at a lack of multi-bagger potential.
ColumnsWall Street Today | Stocks Retreat as Investors Lock in Gains
RECAP
US Stocks Retreat After Rallying in 2023
US stocks pulled back on the first trading day of the year, locking gains posted in 2023, as the Magnificent Seven stocks retreated.
A Bloomberg gauge of the seven stocks declined 1.7%, weighing on the S&P 500 and the Nasdaq that are heavily weighted to the tech giants. The $Nasdaq Composite Index(.IXIC.US$ fell 1.6% to close at 14,765.94, its biggest daily decline since October. The $S&P 500 Index(.SPX.US$ slipped 0...
US Stocks Retreat After Rallying in 2023
US stocks pulled back on the first trading day of the year, locking gains posted in 2023, as the Magnificent Seven stocks retreated.
A Bloomberg gauge of the seven stocks declined 1.7%, weighing on the S&P 500 and the Nasdaq that are heavily weighted to the tech giants. The $Nasdaq Composite Index(.IXIC.US$ fell 1.6% to close at 14,765.94, its biggest daily decline since October. The $S&P 500 Index(.SPX.US$ slipped 0...
36
2
Concern arises over GoodRx Holdings' high P/S ratio as future revenue projections seem insufficient to maintain positive evaluation. Unless significant revenue improvements occur, high P/S values likely unsustainable.
Read more
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg